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Intermittent pneumatic compression of the
foot and calf improves the outcome of
catheter-directed thrombolysis using low-dose
urokinase in patients with acute proximal venous
thrombosis of the leg
Tomohiro Ogawa, MD, PhD, Shunichi Hoshino, MD, PhD, Hirofumi Midorikawa, MD, PhD,
and Kouichi Sato, MD, PhD, Fukushima, Japan
Objective:Catheter-directed thrombolysis (CDT) is a promising treatment of acute proximal deep vein thrombosis (DVT)
to prevent the postthrombotic syndrome by early removal of thrombus. During CDT for DVT patients, the calf muscle
pump is compromised because of immobility. Intermittent pneumatic compression (IPC) can be used to increase venous
flow during bed rest. The CDT with IPC may lyse venous thrombus better than CDT alone. The purpose of this study
was to evaluate the efficiency and safety of IPC during CDT for DVT using low-dose urokinase.
Methods: Twenty-four patients with proximal DVT confirmed by duplex ultrasonography underwent CDT alone (10
cases) and CDT with IPC and a temporary inferior vena cava filter (14 cases) for 3 to 6 days. Pulmonary emboli (PEs)
were assessed by pretreatment and posttreatment pulmonary angiogram or spiral computed tomography of the chest, and
in the CDT/IPC patients, a posttreatment inferior vena cavogram was performed. The initial results were evaluated by
venogram immediately after CDT, and the late results were evaluated by venous disability score and duplex ultrasonog-
raphy 6 to 36 months after treatment.
Results:There was no symptomatic PE in either group. In CDTwith IPC, one new asymptomatic PEwas found, but there
was no large thrombus in the inferior vena cava. The initial thrombolytic results of CDT with IPC were better than those
of CDT alone (five cases of complete lysis in the CDT/IPC group and none in the CDT alone group). In the follow-up,
the deep veins were patent and competent in 43% (6/14) in the CDT/IPC group, compared with 17% (1/6) in the
CDT-alone group. The venous disability score showed that the CDT/IPC group had less disability than the CDT-alone
group.
Conclusions: This pilot study showed that adding IPC to CDT using low-dose urokinase for DVT treatment of the leg
resulted in better early and late outcomes compared with CDT alone and was not associated with an increased risk of
symptomatic PEs. (J Vasc Surg 2005;42:940-4.)It has been reported that catheter-directed thromboly-
sis (CDT) with thrombolytic agents infused into the target
thrombus is more effective for acute proximal deep vein
thrombosis (DVT) than systemic thrombolysis.1 Most of
these studies report the use of high doses of urokinase
administered within short periods.2-7 CDT with a low dose
of urokinase is considered to be insufficient for thrombol-
ysis of DVT.1 In Japan, only 240,000 IU/d urokinase is
covered by health insurance for the thrombolysis of DVT.
To obtain satisfactory results in the treatment of DVT with
this low dose, adjunct methods in CDT may be required.8
CDT is usually performed with the patient in a resting
position, in which the calf muscle pump is less active in
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940facilitating venous flow. Therefore, other means to increase
leg venous flow during CDT could enhance the effective-
ness of thrombolysis. Intermittent pneumatic compression
(IPC), which can facilitate leg venous flow, is commonly
used as prophylaxis for DVT and in the treatment of
chronic venous insufficiency and lymphedema. The pur-
pose of this prospective nonrandomized pilot study with
cohort comparison was to evaluate the effects and safety of
CDT with IPC for acute proximal DVT compared with
CDT alone.
MATERIALS AND METHODS
Twenty-four consecutive patients with anticipated nor-
mal life spans with acute proximal DVT in the legs con-
firmed by duplex ultrasonography and without symptom-
atic pulmonary embolism (PE) underwent CDT (first 10
cases, CDT alone; last 14 cases, CDT with IPC) from
January 2001 to January 2003. The procedures in this
study were approved by the ethics committee of Fukushima
Daiichi Hospital, and all patients participated in this study
after they gave informed consent. The male-female ratio
was 7:3 in the CDT-alone group and 10:4 in the CDT/
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years (range, 52-82 years) in the CDT-alone group and 65
years (range, 20-81 years) in the CDT/IPC group. The
average symptom duration was 2.9 days (range, 0-7 days) in
the CDT-alone group; this was shorter than the 11.8 days
(range, 1-30 days) in CDT/ IPC group (P  .007). The
patients who underwent CDT with IPC had more major
risk factors for DVT than those with IPC alone (Table I ).
In the CDT-alone group, there were four cases of
iliofemoral popliteal thrombus, four cases of iliofemoral
thrombus, one case of iliac thrombus, and one case of
femoropopliteal thrombus, whereas there were six cases of
iliofemoral popliteal thrombus, two of iliofemoral throm-
bus, and six of femoropopliteal thrombus in the CDT/IPC
group (Table I). In one of the two subjects with a history of
DVT, computed tomography (CT) before the new throm-
botic event revealed iliac vein occlusion. This case was
classified as a new femoropopliteal thrombus despite occlu-
sion from the popliteal vein to the iliac vein. The deep
venous condition of the other case with a history of DVT
was unknown. Both patients belonged to the CDT/IPC
group.
The CDT method was as follows:
1. The infusion catheter (5F Fountain infusion catheter;
Merit Medical Inc, South Jordan, Utah) was inserted
through a sheath in a small saphenous vein cutdown into
the popliteal vein up to the proximal part of the throm-
bus in both the CDT-alone group and the CDT/IPC
group. This was important to prevent the possibility of
bleeding at the insertion site under the IPC cuff in the
CDT/IPC group. In the cases in which the proximal
end of the thrombus was localized in the proximal
femoral vein, the catheter was inserted through the
common femoral vein or the femoral vein by percutane-






(n  14) P value
Male/Female 7/3 10/4 .704
Age, y, median (range) 67 (62-82) 73.5 (20-81) .837
Duration of leg symptom,
median (range)* 2.5 (0-7) 8.5 (1-30) .007
Previous DVT 0 2 .617
Previous operation 2 2 .853
Trauma 1 0 .863
Malignant tumor 0 1 .862
Thrombophilia 0 3 .349
Thrombus site
IFP 4 6 .780
IF 4 2 .339
I 1 0 .862
FP 1 6 .197
CDT, Catheter-directed thrombolysis; IPC, intermittent pneumatic com-
pression;DVT, deep vein thrombosis; IFP, iliofemoral popliteal; IF, iliofem-
oral; I, iliac; FP, femoropopliteal.
*days.insertion.2. A temporary inferior vena cava (IVC) filter (8F Toray
Hausprotect temporary IVC filter; Toray Inc, Tokyo,
Japan) was placed in the infrarenal IVC through the
right internal jugular vein to prevent PE in all cases
undergoing CDTwith IPC. This filter was removed just
after the removal of the CDT catheter.
3. Thrombolysis was performed in the following way: at
admission 240,000 IU of urokinase was infused during 1
hour, followed in the next 2 days by a 1-hour infusion of
120,000 IU of urokinase twice daily. The leg was exam-
ined clinically each day, and CDT was terminated when
the leg swelling was resolved, after which a venogram
was performed.
4. The applied IPC device (VenAssist; ACI Medical Inc,
San Marcos, California) consists of two cuffs. The foot
cuff was first rapidly inflated to 80 mm Hg, followed by
inflation of the calf cuff 1 second later to the same
pressure, which was maintained for 6 seconds, after
which the cuffs were deflated for 60 seconds. This cycle
was repeated continuously 24 hours a day from just after
the initial infusion of urokinase until the CDT catheter
was removed.
5. After CDT, a completion venogram was performed
through the infusion catheter repositioned into the
distal part of the involved deep vein, after which the IVC
filter and the infusion catheter were removed.
6. PEs were assessed both clinically and by pulmonary
angiography or spiral CT of the chest, and trapped
thrombus was assessed within the temporary IVC filter
by using an inferior vena cavogram in the CDT/IPC
group. Of the 14 cases in the CDT/IPC group, pulmo-
nary angiography before and after CDT treatment was
performed in nine cases, and spiral CT was performed
after CDT treatment in five cases.
7. Simultaneously with CDT, unfractionated heparin was
administered intravenously with the goal of reaching an
activated partial thromboplastin time ratio from 1.5 to
2.0 within 24 hours, with the addition of orally admin-
istered warfarin. Heparin infusion was stopped when the
international normalized ratio reached 1.5, usually from
3 to 5 days. The international normalized ratio was
controlled to 1.5 to 2.0 for at least 6 months after CDT.
All three patients with thrombophilia continue to take
warfarin. After CDT, all patients were prescribed 20mm
Hg below-knee elastic stockings.
The initial results of thrombolysis were evaluated by
completion venography and were classified into three
grades: grade 1, complete recanalization; grade 2, 50% to
99% lysis; and grade 3, less than 50% lysis.
During follow-up, deep venous reflux and obstruction
were evaluated from the popliteal vein to the common iliac
vein by using duplex ultrasonography (Logic 500; GE
Yokogawa Medical, Tokyo, Japan). Four cases undergoing
CDT alone were not examined by duplex scanning. Venous
reflux was defined as more than 0.5 seconds’ reflux time in
a standing position with cuff compression with the van
Bemmelen technique,9 and obstruction was detected by
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ing in the lying position. Disability was calculated from
interviews by using the venous disability score reported by
Rutherford et al.10 This scoring system permits evaluation
of the severity of postthrombotic disease. A score of 0
represents an asymptomatic condition; 1 is symptomatic
but normally necessitates no stocking; 2 is symptomatic and
necessitates a stocking; and 3 corresponds to an inability to
perform normal activities with the stocking. The median
follow-up periods were 22months (range, 6-36months) in
the CDT-alone group and 14 months (range, 6-26
months) in the CDT/IPC group. There was no significant
difference between groups (P .37). Comparison between
groups was performed with the Mann-Whitney U test for
nonparametric variables and the Yates-corrected Pearson
2test or Fisher exact test for categorical variables. P values
were considered significant at .05.
RESULTS
CDT was terminated after 3 days in all 14 CDT/IPC
patients and in 5 of 10 CDT-alone patients; 5 of these
patients did not show any clinical improvement after 3 days
and continued CDT for another 3 days. The median total
dose of urokinase was 1,020,000 IU (range, 720,000-
1,440,000 IU) in patients undergoing CDT alone, com-
pared with 720,000 IU in the CDT/IPC group (P .01).
Pulmonary embolism. There were no symptomatic
PEs in either group of patients. Additionally, venography
showed no large emboli in the temporary IVC filters, and
no large trapped thrombus was seen in any of the IVC filters
upon removal. Out of the nine patients treated by CDT
with IPC who underwent pulmonary angiography, two
cases were diagnosed as asymptomatic PE located in the
right pulmonary artery before treatment. After treatment,
one of these emboli disappeared, and one new asymptom-
atic embolus of the left pulmonary artery developed in a
different patient. In the five cases treated with CDT with
IPC who did not undergo pulmonary angiography, no PE
was found by CT scanning.
Other complications. There were no major bleeding
episodes such as gastrointestinal bleeding, cerebral bleed-
ing, or bleeding at the catheter-insertion site. There were
complaints of mild calf pain and sleeplessness in three
patients undergoing CDT with IPC; however, these com-
plaints were addressed easily by medication. There was no
complication related to the temporary IVC filter except for
one asymptomatic PE.
Evaluation of initial thrombolysis. At the time of
completion venography, in the CDT-alone group, there
was no case of grade 1 (complete recanalization); 20% of
these cases were grade 2 (50%-99% lysis), and 80% were
grade 3 (50% lysis). In the CDT/IPC group, 36% were
grade 1, 43% were grade 2, and 21% were grade 3 (Table II).
By this measure, thrombolysis in CDT/IPC was more
effective than CDT alone (P  .0037). The percentage of
grade 3 lysis in the CDT/IPC group was significantly
smaller than that in the CDT alone group.Late results. Postthrombotic syndrome in the CDT-
alone group was more severe than in the CDT/IPC group,
on the basis of the observed result that the venous disability
score in the CDT-alone group was higher than in the
CDT/IPC group (median of 1 vs 0; P  .01). Two thirds
of the CDT/IPC group were asymptomatic, compared to
one fifth of the CDT-alone group (Fig 1).
According to evaluation by duplex ultrasonography,
43% of cases undergoing CDT with IPC had no deep
venous obstruction and reflux, compared with 17% (one of
six) of cases undergoing CDT alone. With regard to post-
thrombotic change, 50% of patients showed venous ob-
struction and 33% showed venous reflux and obstruction in
the CDT-alone group, whereas 36% of patients showed
venous obstruction, 7% showed both venous obstruction
and reflux, and 14% showed venous reflux alone in the
CDT/ICP group (Table III). In thse two cases with previ-
ous DVT, deep vein reflux and obstruction was found in
one, and deep vein reflux alone was found in the other.
There was no statistically significant difference between the
rate of competent deep veins in the CDT-alone group and
the CDT/IPC group.
DISCUSSION
This prospective nonrandomized pilot study on CDT
for proximal DVT of the leg using urokinase, with an initial
infusion of 240,000 IU followed by 120,000 IU for 1 hour
twice daily for two more days, showed that the group in
which CDT was combined with IPC of the foot and calf
had a better immediate outcome regarding thrombolysis
(36% complete lysis vs 0%), with no difference in complica-
tion rate (no symptomatic PEs). At follow-up (CDT/IPC,
median 14 months; CDT alone, 22 months) with duplex
ultrasonography, the deep veins were patent and compe-
tent in 43% vs 17%, with less disability. Therefore, it seems
that adding IPC to enhance the venous outflow from the
leg will improve the immediate lysis of the deep veins in
CDT, as well as the postthrombotic sequelae regarding
reflux, obstruction, and disability score. The anticipated
risk of PE with IPCwas not substantiated, so the temporary
IVC filter to prevent possible PE seems to be unnecessary.
The goals of treatment of acute DVT are to prevent the
extension or recurrence of DVT and fatal PE and to mini-
mize the early and late sequelae of DVT. Particularly in
Table II. Initial resolution of DVT
Resolution CDT alone CDT/IPC P value
Grade 1 0 5 (35.7%) .106
Grade 2 2 (20%) 6 (42.9%) .464
Grade 3 8 (80%) 3 (21.4%) .015
DVT, Deep vein thrombosis; CDT, catheter-directed thrombolysis;
IPC, intermittent pneumatic compression.
Grade 1, complete recanalization; grade 2, 50%-99% lysis; grade 3, 50%
lysis.
The overall effect of thrombolysis for CDT with IPC was better than for
CDT alone (P  .0037).proximal DVT, progressive swelling of the leg can lead to
atic
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pressure, which can progress to venous gangrene and limb
loss. Later, the development of severe postthrombotic syn-
drome can result from persistent obstruction of the venous
outflow, loss of valvular competence, or both, and recurrent
PE can lead to chronic pulmonary hypertension. Early throm-
bus removal seems to be logical and beneficial, and the earlier
the removal, the better the outcome. CDT is one option for
early thrombus removal.3 Positive short- and long-term
outcomes of CDT for acute proximal DVT have been
reported.2-7 According to these reports, the complete lysis
rate of CDT for proximal DVT is 20% to 70%, and cases
with good initial results show good patency, venous func-
tion, and quality of life in mid- and long-term follow-up.11
In these studies, 150,000 to 250,000 IU/h of uroki-
Fig 1. Venous disability score after thrombolysis of dee
were from 6 to 36 months (21 months) in the catheter-d
(median, 14.6 months) in the CDT/intermittent pneum
Table III. Evaluation of thrombolysis of DVT using





(14 cases) P value
No obstruction and no reflux 1 (16.6%) 6 (42.8%) .539
Obstruction 3 (50%) 5 (35.7%) .921
Obstruction and reflux 2 (33.3%) 1 (7.1%) .412
Reflux 0 2 (14.2%) .871
DVT, Deep vein thrombosis; CDT, catheter-directed thrombolysis;
IPC, intermittent pneumatic compression.
The follow-up period was 22 months (range, 6-36 months) in the CDT-
alone group and 14 months (range, 6-26 months) in the CDT with IPC
group.nase was delivered continuously for several days, resultingin an average total dose of urokinase ranging from
2,900,000 to 7,800,000 IU.2-7In contrast, the results of
local thrombolysis with low-dose urokinase for proximal
DVT are not better than those of systemic thrombolysis
with high-dose urokinase.12 This corroborates with our
study, in which there was no complete lysis of DVT by
CDT alone with low-dose urokinase.
Adding IPC to the low-dose CDT is effective in in-
creasing leg venous flow. This method likely inhibits the
progression of thrombus and maintains the patency of deep
veins as effectively as walking mobilization reduces the
progression of thrombus in acute DVT treated with anti-
coagulation.13 Although the treatment of DVT with walk-
ing mobilization is effective only in the daytime, IPC can
work around the clock during DVT treatment.
CONCLUSION
This pilot study showed that CDT using low-dose
urokinase in combination with IPC of the foot and calf for
proximal DVT can provide better early and late results
compared with CDT alone, without increasing the risk of
symptomatic PE. However, further large-scale studies are
required.
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